Gelteq (GELS) Equity Ratio (2023 - 2025)
Gelteq (GELS) recorded quarterly Equity Ratio of 0.74 in Q2 2025, up 1.09% quarter-over-quarter from 0.73 in Q2 2024, and up 1.09% on a YoY basis from 0.73 in Q2 2024.
Gelteq (GELS) Equity Ratio (2023 - 2025) Analysis & Trends
Gelteq's Equity Ratio history runs 3 years deep, the most recent figure standing at 0.74 for Q2 2025.
- In Q2 2025, Equity Ratio rose 1.09% year-over-year to 0.74; the TTM figure through Jun 2025 stood at 0.74 (up 1.09% YoY), while the FY2025 annual figure was 0.74, up 1.09% from the prior year.
- Equity Ratio was 0.74 for Q2 2025 at Gelteq, up from 0.73 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.83 in Q2 2023 to a low of 0.73 in Q2 2024.
- Historically, Equity Ratio has averaged 0.76 across 3 years, with a median of 0.74 in 2025.
- The sharpest annual moves came in 2024 and 2025: Equity Ratio dropped 12.23% in 2024, then advanced 1.09% in 2025.
- A 3-year view of Equity Ratio shows it stood at 0.83 in 2023, then decreased by 12.23% to 0.73 in 2024, then advanced by 1.09% to 0.74 in 2025.
- The last three Equity Ratio figures came in at 0.74 (Q2 2025), 0.73 (Q2 2024), and 0.83 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.21 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.21 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.88 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.73 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.69 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.49 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.41 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 0.20 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.52 |
| 10 | Gelteq | 10.57 Mn | 10.34 Mn | - | 0.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.74 |
| Jun 30, 2024 | 0.73 |
| Jun 30, 2023 | 0.83 |